Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dianthus Therapeutics Inc.

21.82
-0.0300-0.14%
Volume:161.76K
Turnover:3.51M
Market Cap:700.99M
PE:-8.55
High:22.05
Open:21.60
Low:21.28
Close:21.85
Loading ...
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Oct 25, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 21, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Sep 21, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 21, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 21, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Sep 21, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Sep 15, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 31, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2023

Correspondence

Form CORRESP - Correspondence
Jul 17, 2023

Correspondence

Form CORRESP - Correspondence